COVID-19 Impact on Global Efavirenz Market Insights, Forecast to 2026
Efavirenz market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Efavirenz market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Efavirenz market is segmented into
The Efavirenz market is analysed and market size information is provided by regions (countries).
The key regions covered in the Efavirenz market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Efavirenz Market Share Analysis
Efavirenz market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Efavirenz business, the date to enter into the Efavirenz market, Efavirenz product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Efavirenz market is segmented into
- Single Efavirenz
- Two-drug combination
- Three-drug combination
- Adults
- Children
The Efavirenz market is analysed and market size information is provided by regions (countries).
The key regions covered in the Efavirenz market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Efavirenz Market Share Analysis
Efavirenz market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Efavirenz business, the date to enter into the Efavirenz market, Efavirenz product introduction, recent developments, etc.
The major vendors covered:
- Bristol-Myers Squibb
- Teva
- Mylan
- Aurobindo Pharma
- Cipla
- Macleods Pharmaceuticals
- Hetero
- Strides Pharma
- Gilead Sciences
1 STUDY COVERAGE
1.1 Efavirenz Product Introduction
1.2 Market Segments
1.3 Key Efavirenz Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Efavirenz Market Size Growth Rate by Type
1.4.2 Single Efavirenz
1.4.3 Two-drug combination
1.4.4 Three-drug combination
1.5 Market by Application
1.5.1 Global Efavirenz Market Size Growth Rate by Application
1.5.2 Adults
1.5.3 Children
1.6 Coronavirus Disease 2019 (Covid-19): Efavirenz Industry Impact
1.6.1 How the Covid-19 is Affecting the Efavirenz Industry
1.6.1.1 Efavirenz Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Efavirenz Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Efavirenz Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Efavirenz Market Size Estimates and Forecasts
2.1.1 Global Efavirenz Revenue 2015-2026
2.1.2 Global Efavirenz Sales 2015-2026
2.2 Efavirenz Market Size by Region: 2020 Versus 2026
2.2.1 Global Efavirenz Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Efavirenz Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL EFAVIRENZ COMPETITOR LANDSCAPE BY PLAYERS
3.1 Efavirenz Sales by Manufacturers
3.1.1 Efavirenz Sales by Manufacturers (2015-2020)
3.1.2 Efavirenz Sales Market Share by Manufacturers (2015-2020)
3.2 Efavirenz Revenue by Manufacturers
3.2.1 Efavirenz Revenue by Manufacturers (2015-2020)
3.2.2 Efavirenz Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Efavirenz Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Efavirenz Revenue in 2019
3.2.5 Global Efavirenz Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Efavirenz Price by Manufacturers
3.4 Efavirenz Manufacturing Base Distribution, Product Types
3.4.1 Efavirenz Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Efavirenz Product Type
3.4.3 Date of International Manufacturers Enter into Efavirenz Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Efavirenz Market Size by Type (2015-2020)
4.1.1 Global Efavirenz Sales by Type (2015-2020)
4.1.2 Global Efavirenz Revenue by Type (2015-2020)
4.1.3 Efavirenz Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Efavirenz Market Size Forecast by Type (2021-2026)
4.2.1 Global Efavirenz Sales Forecast by Type (2021-2026)
4.2.2 Global Efavirenz Revenue Forecast by Type (2021-2026)
4.2.3 Efavirenz Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Efavirenz Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Efavirenz Market Size by Application (2015-2020)
5.1.1 Global Efavirenz Sales by Application (2015-2020)
5.1.2 Global Efavirenz Revenue by Application (2015-2020)
5.1.3 Efavirenz Price by Application (2015-2020)
5.2 Efavirenz Market Size Forecast by Application (2021-2026)
5.2.1 Global Efavirenz Sales Forecast by Application (2021-2026)
5.2.2 Global Efavirenz Revenue Forecast by Application (2021-2026)
5.2.3 Global Efavirenz Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Efavirenz by Country
6.1.1 North America Efavirenz Sales by Country
6.1.2 North America Efavirenz Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Efavirenz Market Facts & Figures by Type
6.3 North America Efavirenz Market Facts & Figures by Application
7 EUROPE
7.1 Europe Efavirenz by Country
7.1.1 Europe Efavirenz Sales by Country
7.1.2 Europe Efavirenz Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Efavirenz Market Facts & Figures by Type
7.3 Europe Efavirenz Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Efavirenz by Region
8.1.1 Asia Pacific Efavirenz Sales by Region
8.1.2 Asia Pacific Efavirenz Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Efavirenz Market Facts & Figures by Type
8.3 Asia Pacific Efavirenz Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Efavirenz by Country
9.1.1 Latin America Efavirenz Sales by Country
9.1.2 Latin America Efavirenz Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Efavirenz Market Facts & Figures by Type
9.3 Central & South America Efavirenz Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Efavirenz by Country
10.1.1 Middle East and Africa Efavirenz Sales by Country
10.1.2 Middle East and Africa Efavirenz Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Efavirenz Market Facts & Figures by Type
10.3 Middle East and Africa Efavirenz Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb Efavirenz Products Offered
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Description, Business Overview and Total Revenue
11.2.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Teva Efavirenz Products Offered
11.2.5 Teva Recent Development
11.3 Mylan
11.3.1 Mylan Corporation Information
11.3.2 Mylan Description, Business Overview and Total Revenue
11.3.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Mylan Efavirenz Products Offered
11.3.5 Mylan Recent Development
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Corporation Information
11.4.2 Aurobindo Pharma Description, Business Overview and Total Revenue
11.4.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Aurobindo Pharma Efavirenz Products Offered
11.4.5 Aurobindo Pharma Recent Development
11.5 Cipla
11.5.1 Cipla Corporation Information
11.5.2 Cipla Description, Business Overview and Total Revenue
11.5.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Cipla Efavirenz Products Offered
11.5.5 Cipla Recent Development
11.6 Macleods Pharmaceuticals
11.6.1 Macleods Pharmaceuticals Corporation Information
11.6.2 Macleods Pharmaceuticals Description, Business Overview and Total Revenue
11.6.3 Macleods Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Macleods Pharmaceuticals Efavirenz Products Offered
11.6.5 Macleods Pharmaceuticals Recent Development
11.7 Hetero
11.7.1 Hetero Corporation Information
11.7.2 Hetero Description, Business Overview and Total Revenue
11.7.3 Hetero Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hetero Efavirenz Products Offered
11.7.5 Hetero Recent Development
11.8 Strides Pharma
11.8.1 Strides Pharma Corporation Information
11.8.2 Strides Pharma Description, Business Overview and Total Revenue
11.8.3 Strides Pharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Strides Pharma Efavirenz Products Offered
11.8.5 Strides Pharma Recent Development
11.9 Gilead Sciences
11.9.1 Gilead Sciences Corporation Information
11.9.2 Gilead Sciences Description, Business Overview and Total Revenue
11.9.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Gilead Sciences Efavirenz Products Offered
11.9.5 Gilead Sciences Recent Development
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb Efavirenz Products Offered
11.1.5 Bristol-Myers Squibb Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Efavirenz Market Estimates and Projections by Region
12.1.1 Global Efavirenz Sales Forecast by Regions 2021-2026
12.1.2 Global Efavirenz Revenue Forecast by Regions 2021-2026
12.2 North America Efavirenz Market Size Forecast (2021-2026)
12.2.1 North America: Efavirenz Sales Forecast (2021-2026)
12.2.2 North America: Efavirenz Revenue Forecast (2021-2026)
12.2.3 North America: Efavirenz Market Size Forecast by Country (2021-2026)
12.3 Europe Efavirenz Market Size Forecast (2021-2026)
12.3.1 Europe: Efavirenz Sales Forecast (2021-2026)
12.3.2 Europe: Efavirenz Revenue Forecast (2021-2026)
12.3.3 Europe: Efavirenz Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Efavirenz Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Efavirenz Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Efavirenz Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Efavirenz Market Size Forecast by Region (2021-2026)
12.5 Latin America Efavirenz Market Size Forecast (2021-2026)
12.5.1 Latin America: Efavirenz Sales Forecast (2021-2026)
12.5.2 Latin America: Efavirenz Revenue Forecast (2021-2026)
12.5.3 Latin America: Efavirenz Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Efavirenz Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Efavirenz Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Efavirenz Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Efavirenz Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Efavirenz Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Efavirenz Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Efavirenz Product Introduction
1.2 Market Segments
1.3 Key Efavirenz Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Efavirenz Market Size Growth Rate by Type
1.4.2 Single Efavirenz
1.4.3 Two-drug combination
1.4.4 Three-drug combination
1.5 Market by Application
1.5.1 Global Efavirenz Market Size Growth Rate by Application
1.5.2 Adults
1.5.3 Children
1.6 Coronavirus Disease 2019 (Covid-19): Efavirenz Industry Impact
1.6.1 How the Covid-19 is Affecting the Efavirenz Industry
1.6.1.1 Efavirenz Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Efavirenz Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Efavirenz Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Efavirenz Market Size Estimates and Forecasts
2.1.1 Global Efavirenz Revenue 2015-2026
2.1.2 Global Efavirenz Sales 2015-2026
2.2 Efavirenz Market Size by Region: 2020 Versus 2026
2.2.1 Global Efavirenz Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Efavirenz Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL EFAVIRENZ COMPETITOR LANDSCAPE BY PLAYERS
3.1 Efavirenz Sales by Manufacturers
3.1.1 Efavirenz Sales by Manufacturers (2015-2020)
3.1.2 Efavirenz Sales Market Share by Manufacturers (2015-2020)
3.2 Efavirenz Revenue by Manufacturers
3.2.1 Efavirenz Revenue by Manufacturers (2015-2020)
3.2.2 Efavirenz Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Efavirenz Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Efavirenz Revenue in 2019
3.2.5 Global Efavirenz Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Efavirenz Price by Manufacturers
3.4 Efavirenz Manufacturing Base Distribution, Product Types
3.4.1 Efavirenz Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Efavirenz Product Type
3.4.3 Date of International Manufacturers Enter into Efavirenz Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Efavirenz Market Size by Type (2015-2020)
4.1.1 Global Efavirenz Sales by Type (2015-2020)
4.1.2 Global Efavirenz Revenue by Type (2015-2020)
4.1.3 Efavirenz Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Efavirenz Market Size Forecast by Type (2021-2026)
4.2.1 Global Efavirenz Sales Forecast by Type (2021-2026)
4.2.2 Global Efavirenz Revenue Forecast by Type (2021-2026)
4.2.3 Efavirenz Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Efavirenz Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Efavirenz Market Size by Application (2015-2020)
5.1.1 Global Efavirenz Sales by Application (2015-2020)
5.1.2 Global Efavirenz Revenue by Application (2015-2020)
5.1.3 Efavirenz Price by Application (2015-2020)
5.2 Efavirenz Market Size Forecast by Application (2021-2026)
5.2.1 Global Efavirenz Sales Forecast by Application (2021-2026)
5.2.2 Global Efavirenz Revenue Forecast by Application (2021-2026)
5.2.3 Global Efavirenz Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Efavirenz by Country
6.1.1 North America Efavirenz Sales by Country
6.1.2 North America Efavirenz Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Efavirenz Market Facts & Figures by Type
6.3 North America Efavirenz Market Facts & Figures by Application
7 EUROPE
7.1 Europe Efavirenz by Country
7.1.1 Europe Efavirenz Sales by Country
7.1.2 Europe Efavirenz Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Efavirenz Market Facts & Figures by Type
7.3 Europe Efavirenz Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Efavirenz by Region
8.1.1 Asia Pacific Efavirenz Sales by Region
8.1.2 Asia Pacific Efavirenz Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Efavirenz Market Facts & Figures by Type
8.3 Asia Pacific Efavirenz Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Efavirenz by Country
9.1.1 Latin America Efavirenz Sales by Country
9.1.2 Latin America Efavirenz Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Efavirenz Market Facts & Figures by Type
9.3 Central & South America Efavirenz Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Efavirenz by Country
10.1.1 Middle East and Africa Efavirenz Sales by Country
10.1.2 Middle East and Africa Efavirenz Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Efavirenz Market Facts & Figures by Type
10.3 Middle East and Africa Efavirenz Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb Efavirenz Products Offered
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Description, Business Overview and Total Revenue
11.2.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Teva Efavirenz Products Offered
11.2.5 Teva Recent Development
11.3 Mylan
11.3.1 Mylan Corporation Information
11.3.2 Mylan Description, Business Overview and Total Revenue
11.3.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Mylan Efavirenz Products Offered
11.3.5 Mylan Recent Development
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Corporation Information
11.4.2 Aurobindo Pharma Description, Business Overview and Total Revenue
11.4.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Aurobindo Pharma Efavirenz Products Offered
11.4.5 Aurobindo Pharma Recent Development
11.5 Cipla
11.5.1 Cipla Corporation Information
11.5.2 Cipla Description, Business Overview and Total Revenue
11.5.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Cipla Efavirenz Products Offered
11.5.5 Cipla Recent Development
11.6 Macleods Pharmaceuticals
11.6.1 Macleods Pharmaceuticals Corporation Information
11.6.2 Macleods Pharmaceuticals Description, Business Overview and Total Revenue
11.6.3 Macleods Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Macleods Pharmaceuticals Efavirenz Products Offered
11.6.5 Macleods Pharmaceuticals Recent Development
11.7 Hetero
11.7.1 Hetero Corporation Information
11.7.2 Hetero Description, Business Overview and Total Revenue
11.7.3 Hetero Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hetero Efavirenz Products Offered
11.7.5 Hetero Recent Development
11.8 Strides Pharma
11.8.1 Strides Pharma Corporation Information
11.8.2 Strides Pharma Description, Business Overview and Total Revenue
11.8.3 Strides Pharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Strides Pharma Efavirenz Products Offered
11.8.5 Strides Pharma Recent Development
11.9 Gilead Sciences
11.9.1 Gilead Sciences Corporation Information
11.9.2 Gilead Sciences Description, Business Overview and Total Revenue
11.9.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Gilead Sciences Efavirenz Products Offered
11.9.5 Gilead Sciences Recent Development
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb Efavirenz Products Offered
11.1.5 Bristol-Myers Squibb Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Efavirenz Market Estimates and Projections by Region
12.1.1 Global Efavirenz Sales Forecast by Regions 2021-2026
12.1.2 Global Efavirenz Revenue Forecast by Regions 2021-2026
12.2 North America Efavirenz Market Size Forecast (2021-2026)
12.2.1 North America: Efavirenz Sales Forecast (2021-2026)
12.2.2 North America: Efavirenz Revenue Forecast (2021-2026)
12.2.3 North America: Efavirenz Market Size Forecast by Country (2021-2026)
12.3 Europe Efavirenz Market Size Forecast (2021-2026)
12.3.1 Europe: Efavirenz Sales Forecast (2021-2026)
12.3.2 Europe: Efavirenz Revenue Forecast (2021-2026)
12.3.3 Europe: Efavirenz Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Efavirenz Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Efavirenz Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Efavirenz Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Efavirenz Market Size Forecast by Region (2021-2026)
12.5 Latin America Efavirenz Market Size Forecast (2021-2026)
12.5.1 Latin America: Efavirenz Sales Forecast (2021-2026)
12.5.2 Latin America: Efavirenz Revenue Forecast (2021-2026)
12.5.3 Latin America: Efavirenz Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Efavirenz Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Efavirenz Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Efavirenz Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Efavirenz Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Efavirenz Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Efavirenz Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Efavirenz Market Segments
Table 2. Ranking of Global Top Efavirenz Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Efavirenz Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Single Efavirenz
Table 5. Major Manufacturers of Two-drug combination
Table 6. Major Manufacturers of Three-drug combination
Table 7. COVID-19 Impact Global Market: (Four Efavirenz Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Efavirenz Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Efavirenz Players to Combat Covid-19 Impact
Table 12. Global Efavirenz Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Efavirenz Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Efavirenz Sales by Regions 2015-2020 (K Units)
Table 15. Global Efavirenz Sales Market Share by Regions (2015-2020)
Table 16. Global Efavirenz Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Efavirenz Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Efavirenz Sales Share by Manufacturers (2015-2020)
Table 19. Global Efavirenz Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Efavirenz by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Efavirenz as of 2019)
Table 21. Efavirenz Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Efavirenz Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Efavirenz Price (2015-2020) (USD/Unit)
Table 24. Efavirenz Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Efavirenz Product Type
Table 26. Date of International Manufacturers Enter into Efavirenz Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Efavirenz Sales by Type (2015-2020) (K Units)
Table 29. Global Efavirenz Sales Share by Type (2015-2020)
Table 30. Global Efavirenz Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Efavirenz Revenue Share by Type (2015-2020)
Table 32. Efavirenz Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Efavirenz Sales by Application (2015-2020) (K Units)
Table 34. Global Efavirenz Sales Share by Application (2015-2020)
Table 35. North America Efavirenz Sales by Country (2015-2020) (K Units)
Table 36. North America Efavirenz Sales Market Share by Country (2015-2020)
Table 37. North America Efavirenz Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Efavirenz Revenue Market Share by Country (2015-2020)
Table 39. North America Efavirenz Sales by Type (2015-2020) (K Units)
Table 40. North America Efavirenz Sales Market Share by Type (2015-2020)
Table 41. North America Efavirenz Sales by Application (2015-2020) (K Units)
Table 42. North America Efavirenz Sales Market Share by Application (2015-2020)
Table 43. Europe Efavirenz Sales by Country (2015-2020) (K Units)
Table 44. Europe Efavirenz Sales Market Share by Country (2015-2020)
Table 45. Europe Efavirenz Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Efavirenz Revenue Market Share by Country (2015-2020)
Table 47. Europe Efavirenz Sales by Type (2015-2020) (K Units)
Table 48. Europe Efavirenz Sales Market Share by Type (2015-2020)
Table 49. Europe Efavirenz Sales by Application (2015-2020) (K Units)
Table 50. Europe Efavirenz Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Efavirenz Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Efavirenz Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Efavirenz Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Efavirenz Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Efavirenz Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Efavirenz Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Efavirenz Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Efavirenz Sales Market Share by Application (2015-2020)
Table 59. Latin America Efavirenz Sales by Country (2015-2020) (K Units)
Table 60. Latin America Efavirenz Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Efavirenz Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Efavirenz Revenue Market Share by Country (2015-2020)
Table 63. Latin America Efavirenz Sales by Type (2015-2020) (K Units)
Table 64. Latin America Efavirenz Sales Market Share by Type (2015-2020)
Table 65. Latin America Efavirenz Sales by Application (2015-2020) (K Units)
Table 66. Latin America Efavirenz Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Efavirenz Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Efavirenz Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Efavirenz Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Efavirenz Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Efavirenz Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Efavirenz Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Efavirenz Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Efavirenz Sales Market Share by Application (2015-2020)
Table 75. Bristol-Myers Squibb Corporation Information
Table 76. Bristol-Myers Squibb Description and Major Businesses
Table 77. Bristol-Myers Squibb Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Bristol-Myers Squibb Product
Table 79. Bristol-Myers Squibb Recent Development
Table 80. Teva Corporation Information
Table 81. Teva Description and Major Businesses
Table 82. Teva Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Teva Product
Table 84. Teva Recent Development
Table 85. Mylan Corporation Information
Table 86. Mylan Description and Major Businesses
Table 87. Mylan Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Mylan Product
Table 89. Mylan Recent Development
Table 90. Aurobindo Pharma Corporation Information
Table 91. Aurobindo Pharma Description and Major Businesses
Table 92. Aurobindo Pharma Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Aurobindo Pharma Product
Table 94. Aurobindo Pharma Recent Development
Table 95. Cipla Corporation Information
Table 96. Cipla Description and Major Businesses
Table 97. Cipla Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Cipla Product
Table 99. Cipla Recent Development
Table 100. Macleods Pharmaceuticals Corporation Information
Table 101. Macleods Pharmaceuticals Description and Major Businesses
Table 102. Macleods Pharmaceuticals Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Macleods Pharmaceuticals Product
Table 104. Macleods Pharmaceuticals Recent Development
Table 105. Hetero Corporation Information
Table 106. Hetero Description and Major Businesses
Table 107. Hetero Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Hetero Product
Table 109. Hetero Recent Development
Table 110. Strides Pharma Corporation Information
Table 111. Strides Pharma Description and Major Businesses
Table 112. Strides Pharma Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Strides Pharma Product
Table 114. Strides Pharma Recent Development
Table 115. Gilead Sciences Corporation Information
Table 116. Gilead Sciences Description and Major Businesses
Table 117. Gilead Sciences Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Gilead Sciences Product
Table 119. Gilead Sciences Recent Development
Table 120. Global Efavirenz Sales Forecast by Regions (2021-2026) (K Units)
Table 121. Global Efavirenz Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global Efavirenz Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global Efavirenz Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: Efavirenz Sales Forecast by Country (2021-2026) (K Units)
Table 125. North America: Efavirenz Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: Efavirenz Sales Forecast by Country (2021-2026) (K Units)
Table 127. Europe: Efavirenz Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: Efavirenz Sales Forecast by Region (2021-2026) (K Units)
Table 129. Asia Pacific: Efavirenz Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: Efavirenz Sales Forecast by Country (2021-2026) (K Units)
Table 131. Latin America: Efavirenz Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: Efavirenz Sales Forecast by Country (2021-2026) (K Units)
Table 133. Middle East and Africa: Efavirenz Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Efavirenz Players
Table 138. Efavirenz Customers List
Table 139. Efavirenz Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
Table 1. Efavirenz Market Segments
Table 2. Ranking of Global Top Efavirenz Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Efavirenz Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Single Efavirenz
Table 5. Major Manufacturers of Two-drug combination
Table 6. Major Manufacturers of Three-drug combination
Table 7. COVID-19 Impact Global Market: (Four Efavirenz Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Efavirenz Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Efavirenz Players to Combat Covid-19 Impact
Table 12. Global Efavirenz Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Efavirenz Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Efavirenz Sales by Regions 2015-2020 (K Units)
Table 15. Global Efavirenz Sales Market Share by Regions (2015-2020)
Table 16. Global Efavirenz Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Efavirenz Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Efavirenz Sales Share by Manufacturers (2015-2020)
Table 19. Global Efavirenz Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Efavirenz by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Efavirenz as of 2019)
Table 21. Efavirenz Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Efavirenz Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Efavirenz Price (2015-2020) (USD/Unit)
Table 24. Efavirenz Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Efavirenz Product Type
Table 26. Date of International Manufacturers Enter into Efavirenz Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Efavirenz Sales by Type (2015-2020) (K Units)
Table 29. Global Efavirenz Sales Share by Type (2015-2020)
Table 30. Global Efavirenz Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Efavirenz Revenue Share by Type (2015-2020)
Table 32. Efavirenz Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Efavirenz Sales by Application (2015-2020) (K Units)
Table 34. Global Efavirenz Sales Share by Application (2015-2020)
Table 35. North America Efavirenz Sales by Country (2015-2020) (K Units)
Table 36. North America Efavirenz Sales Market Share by Country (2015-2020)
Table 37. North America Efavirenz Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Efavirenz Revenue Market Share by Country (2015-2020)
Table 39. North America Efavirenz Sales by Type (2015-2020) (K Units)
Table 40. North America Efavirenz Sales Market Share by Type (2015-2020)
Table 41. North America Efavirenz Sales by Application (2015-2020) (K Units)
Table 42. North America Efavirenz Sales Market Share by Application (2015-2020)
Table 43. Europe Efavirenz Sales by Country (2015-2020) (K Units)
Table 44. Europe Efavirenz Sales Market Share by Country (2015-2020)
Table 45. Europe Efavirenz Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Efavirenz Revenue Market Share by Country (2015-2020)
Table 47. Europe Efavirenz Sales by Type (2015-2020) (K Units)
Table 48. Europe Efavirenz Sales Market Share by Type (2015-2020)
Table 49. Europe Efavirenz Sales by Application (2015-2020) (K Units)
Table 50. Europe Efavirenz Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Efavirenz Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Efavirenz Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Efavirenz Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Efavirenz Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Efavirenz Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Efavirenz Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Efavirenz Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Efavirenz Sales Market Share by Application (2015-2020)
Table 59. Latin America Efavirenz Sales by Country (2015-2020) (K Units)
Table 60. Latin America Efavirenz Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Efavirenz Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Efavirenz Revenue Market Share by Country (2015-2020)
Table 63. Latin America Efavirenz Sales by Type (2015-2020) (K Units)
Table 64. Latin America Efavirenz Sales Market Share by Type (2015-2020)
Table 65. Latin America Efavirenz Sales by Application (2015-2020) (K Units)
Table 66. Latin America Efavirenz Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Efavirenz Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Efavirenz Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Efavirenz Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Efavirenz Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Efavirenz Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Efavirenz Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Efavirenz Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Efavirenz Sales Market Share by Application (2015-2020)
Table 75. Bristol-Myers Squibb Corporation Information
Table 76. Bristol-Myers Squibb Description and Major Businesses
Table 77. Bristol-Myers Squibb Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Bristol-Myers Squibb Product
Table 79. Bristol-Myers Squibb Recent Development
Table 80. Teva Corporation Information
Table 81. Teva Description and Major Businesses
Table 82. Teva Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Teva Product
Table 84. Teva Recent Development
Table 85. Mylan Corporation Information
Table 86. Mylan Description and Major Businesses
Table 87. Mylan Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Mylan Product
Table 89. Mylan Recent Development
Table 90. Aurobindo Pharma Corporation Information
Table 91. Aurobindo Pharma Description and Major Businesses
Table 92. Aurobindo Pharma Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Aurobindo Pharma Product
Table 94. Aurobindo Pharma Recent Development
Table 95. Cipla Corporation Information
Table 96. Cipla Description and Major Businesses
Table 97. Cipla Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Cipla Product
Table 99. Cipla Recent Development
Table 100. Macleods Pharmaceuticals Corporation Information
Table 101. Macleods Pharmaceuticals Description and Major Businesses
Table 102. Macleods Pharmaceuticals Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Macleods Pharmaceuticals Product
Table 104. Macleods Pharmaceuticals Recent Development
Table 105. Hetero Corporation Information
Table 106. Hetero Description and Major Businesses
Table 107. Hetero Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Hetero Product
Table 109. Hetero Recent Development
Table 110. Strides Pharma Corporation Information
Table 111. Strides Pharma Description and Major Businesses
Table 112. Strides Pharma Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Strides Pharma Product
Table 114. Strides Pharma Recent Development
Table 115. Gilead Sciences Corporation Information
Table 116. Gilead Sciences Description and Major Businesses
Table 117. Gilead Sciences Efavirenz Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Gilead Sciences Product
Table 119. Gilead Sciences Recent Development
Table 120. Global Efavirenz Sales Forecast by Regions (2021-2026) (K Units)
Table 121. Global Efavirenz Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global Efavirenz Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global Efavirenz Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: Efavirenz Sales Forecast by Country (2021-2026) (K Units)
Table 125. North America: Efavirenz Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: Efavirenz Sales Forecast by Country (2021-2026) (K Units)
Table 127. Europe: Efavirenz Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: Efavirenz Sales Forecast by Region (2021-2026) (K Units)
Table 129. Asia Pacific: Efavirenz Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: Efavirenz Sales Forecast by Country (2021-2026) (K Units)
Table 131. Latin America: Efavirenz Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: Efavirenz Sales Forecast by Country (2021-2026) (K Units)
Table 133. Middle East and Africa: Efavirenz Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Efavirenz Players
Table 138. Efavirenz Customers List
Table 139. Efavirenz Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Efavirenz Product Picture
Figure 2. Global Efavirenz Sales Market Share by Type in 2020 & 2026
Figure 3. Single Efavirenz Product Picture
Figure 4. Two-drug combination Product Picture
Figure 5. Three-drug combination Product Picture
Figure 6. Global Efavirenz Sales Market Share by Application in 2020 & 2026
Figure 7. Adults
Figure 8. Children
Figure 9. Efavirenz Report Years Considered
Figure 10. Global Efavirenz Market Size 2015-2026 (US$ Million)
Figure 11. Global Efavirenz Sales 2015-2026 (K Units)
Figure 12. Global Efavirenz Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Efavirenz Sales Market Share by Region (2015-2020)
Figure 14. Global Efavirenz Sales Market Share by Region in 2019
Figure 15. Global Efavirenz Revenue Market Share by Region (2015-2020)
Figure 16. Global Efavirenz Revenue Market Share by Region in 2019
Figure 17. Global Efavirenz Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Efavirenz Revenue in 2019
Figure 19. Efavirenz Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Efavirenz Sales Market Share by Type (2015-2020)
Figure 21. Global Efavirenz Sales Market Share by Type in 2019
Figure 22. Global Efavirenz Revenue Market Share by Type (2015-2020)
Figure 23. Global Efavirenz Revenue Market Share by Type in 2019
Figure 24. Global Efavirenz Market Share by Price Range (2015-2020)
Figure 25. Global Efavirenz Sales Market Share by Application (2015-2020)
Figure 26. Global Efavirenz Sales Market Share by Application in 2019
Figure 27. Global Efavirenz Revenue Market Share by Application (2015-2020)
Figure 28. Global Efavirenz Revenue Market Share by Application in 2019
Figure 29. North America Efavirenz Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Efavirenz Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Efavirenz Sales Market Share by Country in 2019
Figure 32. North America Efavirenz Revenue Market Share by Country in 2019
Figure 33. U.S. Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Efavirenz Market Share by Type in 2019
Figure 38. North America Efavirenz Market Share by Application in 2019
Figure 39. Europe Efavirenz Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Efavirenz Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Efavirenz Sales Market Share by Country in 2019
Figure 42. Europe Efavirenz Revenue Market Share by Country in 2019
Figure 43. Germany Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Efavirenz Market Share by Type in 2019
Figure 54. Europe Efavirenz Market Share by Application in 2019
Figure 55. Asia Pacific Efavirenz Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Efavirenz Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Efavirenz Sales Market Share by Region in 2019
Figure 58. Asia Pacific Efavirenz Revenue Market Share by Region in 2019
Figure 59. China Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Efavirenz Market Share by Type in 2019
Figure 82. Asia Pacific Efavirenz Market Share by Application in 2019
Figure 83. Latin America Efavirenz Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Efavirenz Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Efavirenz Sales Market Share by Country in 2019
Figure 86. Latin America Efavirenz Revenue Market Share by Country in 2019
Figure 87. Mexico Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Efavirenz Market Share by Type in 2019
Figure 94. Latin America Efavirenz Market Share by Application in 2019
Figure 95. Middle East and Africa Efavirenz Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Efavirenz Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Efavirenz Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Efavirenz Revenue Market Share by Country in 2019
Figure 99. Turkey Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Efavirenz Market Share by Type in 2019
Figure 106. Middle East and Africa Efavirenz Market Share by Application in 2019
Figure 107. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Macleods Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Hetero Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Strides Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Efavirenz Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. North America Efavirenz Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Efavirenz Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Europe Efavirenz Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Efavirenz Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Asia Pacific Efavirenz Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Efavirenz Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Latin America Efavirenz Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Efavirenz Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Middle East and Africa Efavirenz Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
Figure 1. Efavirenz Product Picture
Figure 2. Global Efavirenz Sales Market Share by Type in 2020 & 2026
Figure 3. Single Efavirenz Product Picture
Figure 4. Two-drug combination Product Picture
Figure 5. Three-drug combination Product Picture
Figure 6. Global Efavirenz Sales Market Share by Application in 2020 & 2026
Figure 7. Adults
Figure 8. Children
Figure 9. Efavirenz Report Years Considered
Figure 10. Global Efavirenz Market Size 2015-2026 (US$ Million)
Figure 11. Global Efavirenz Sales 2015-2026 (K Units)
Figure 12. Global Efavirenz Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Efavirenz Sales Market Share by Region (2015-2020)
Figure 14. Global Efavirenz Sales Market Share by Region in 2019
Figure 15. Global Efavirenz Revenue Market Share by Region (2015-2020)
Figure 16. Global Efavirenz Revenue Market Share by Region in 2019
Figure 17. Global Efavirenz Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Efavirenz Revenue in 2019
Figure 19. Efavirenz Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Efavirenz Sales Market Share by Type (2015-2020)
Figure 21. Global Efavirenz Sales Market Share by Type in 2019
Figure 22. Global Efavirenz Revenue Market Share by Type (2015-2020)
Figure 23. Global Efavirenz Revenue Market Share by Type in 2019
Figure 24. Global Efavirenz Market Share by Price Range (2015-2020)
Figure 25. Global Efavirenz Sales Market Share by Application (2015-2020)
Figure 26. Global Efavirenz Sales Market Share by Application in 2019
Figure 27. Global Efavirenz Revenue Market Share by Application (2015-2020)
Figure 28. Global Efavirenz Revenue Market Share by Application in 2019
Figure 29. North America Efavirenz Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Efavirenz Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Efavirenz Sales Market Share by Country in 2019
Figure 32. North America Efavirenz Revenue Market Share by Country in 2019
Figure 33. U.S. Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Efavirenz Market Share by Type in 2019
Figure 38. North America Efavirenz Market Share by Application in 2019
Figure 39. Europe Efavirenz Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Efavirenz Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Efavirenz Sales Market Share by Country in 2019
Figure 42. Europe Efavirenz Revenue Market Share by Country in 2019
Figure 43. Germany Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Efavirenz Market Share by Type in 2019
Figure 54. Europe Efavirenz Market Share by Application in 2019
Figure 55. Asia Pacific Efavirenz Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Efavirenz Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Efavirenz Sales Market Share by Region in 2019
Figure 58. Asia Pacific Efavirenz Revenue Market Share by Region in 2019
Figure 59. China Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Efavirenz Market Share by Type in 2019
Figure 82. Asia Pacific Efavirenz Market Share by Application in 2019
Figure 83. Latin America Efavirenz Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Efavirenz Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Efavirenz Sales Market Share by Country in 2019
Figure 86. Latin America Efavirenz Revenue Market Share by Country in 2019
Figure 87. Mexico Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Efavirenz Market Share by Type in 2019
Figure 94. Latin America Efavirenz Market Share by Application in 2019
Figure 95. Middle East and Africa Efavirenz Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Efavirenz Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Efavirenz Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Efavirenz Revenue Market Share by Country in 2019
Figure 99. Turkey Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Efavirenz Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Efavirenz Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Efavirenz Market Share by Type in 2019
Figure 106. Middle East and Africa Efavirenz Market Share by Application in 2019
Figure 107. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Macleods Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Hetero Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Strides Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Efavirenz Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. North America Efavirenz Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Efavirenz Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Europe Efavirenz Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Efavirenz Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Asia Pacific Efavirenz Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Efavirenz Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Latin America Efavirenz Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Efavirenz Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Middle East and Africa Efavirenz Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
